Furthermore, IgG purified from patients with APS displayed higher avidity for thrombin, and significantly inhibited antithrombin-III inactivation of thrombin compared with IgG from SLE/aPL+ (without APS) and healthy control subjects (HC)16. This evidence concerns the gene SERPINC1 and systemic lupus erythematosus.